Nvidia Shares Dip PostEarnings Sellers May Be Overlooking LongTerm Fundamentals China Urges APEC Cooperation as Commerce Minister Skips Meeting Over Urgent Business Anthropic and Microsoft Explore AI Chip Collaboration Following 5 Billion Investment Tulsi Gabbard Resigns as Director of National Intelligence Marking Another Cabinet Departure India Tightens Control on Pregabalin Reclassification Under Schedule H1 to Curb Misuse Indian Stock Market to Remain Closed on May 28 for Bakri Id Holiday OCCIN Q1 2026 Earnings Significant EPS Miss Amid Operating Challenges JBI Q1 2026 Earnings EPS Falls 89 Short of Estimates as Stock Gains 199 FirstCash Holdings FCFS Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4 SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Progress LYB Q1 2026 Earnings EPS Surges 140 Above Estimates Amid Improved Operations NextNav Inc NN Faces Sharp Decline Testing Key Support Levels Hewlett Packard Enterprise HPE Declines 33 Key Support Levels Under Scrutiny Old Republic International Declines Testing Key Support Levels as ORI Falls 264 MGRE Preferred Notes Hold Steady Near Support Amid Stable Yield Environment Ready Capital RC Shows Resilience Bounces from Support Eyes Resistance at 192 Bill Gates Discusses Meeting with Trump Musks DOGE and Childhood in WSJ Interview Ahead of Source Code Book Q4 Earnings Season Shows Mixed Results Across Key Sectors Full Truck Alliance Surpasses Market Expectations as Freight Orders See DoubleDigit Growth AI Industry Emerges as Key Beneficiary of MuskAltman Trial Proceedings California Chemical Leak Emergency Raises Concerns for Chemical Industry and Local Economy Geopolitical Tensions Rise as Taiwan Arms Sales Emerge as Key Topic in TrumpXi Talks Analyst Report Highlights Walmarts Resilience Amid Evolving Consumer Landscape Vishay Q1 2026 Earnings EPS Surges Past Estimates Shares Rally Over 12 Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance